Stockreport

Royalty Pharma PLC (RPRX) Earnings Report: A Detailed Analysis [Yahoo! Finance]

Royalty Pharma plc - Class A Ordinary Shares  (RPRX) 
US:NASDAQ Investor Relations: ir.reprosrx.com/investor-relations
PDF Operating Activities : Net cash provided by operating activities reached $773 million in Q4 and $2,988 million for FY 2023. Transactions : Announced transactions valu [Read more]